Related Experiment Videos
Current concepts in the treatment of recurrent aphthous ulcers
Lavonn A Williams1, Bethany L Bramwell
1International Journal of Pharmaceutical Compounding Edmond, Oklahoma.
Abstract:
Recurrent aphthous ulcers are a common oral mucosal condition affecting about 20 percent of the general population and characterized by recurrent ulcers on the nonkeratinized mucosa. The majority of patients with recurrent aphthous ulcers tend to be healthy, although appropriate management of recurrent aphthous ulcers includes ruling out an oral manifestation of systemic disease. Management involves controlling active disease locally to reduce pain and maintain function and reducing the frequency and severity of recurrences, with a goal of a prolonged remission.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease III: Clinical Manifestations and Complications